CVS Health Corp. (CVS) — Financial statements
Income statement, balance sheet, and cash flow for CVS Health Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 402,067↑7.8% | 372,809↑4.2% | 357,776↑10.9% | 322,467↑10.4% | 292,111 | |
| Cost of Revenue | 346,705↑7.9% | 321,408↑6.0% | 303,345↑13.2% | 267,965↑11.7% | 239,991 | |
| Gross Profit | 55,362↑7.7% | 51,401↓5.6% | 54,431↓0.1% | 54,502↑4.6% | 52,120 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 40,240 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 989 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↓100.0% | 41,229 | 0.00 | 0.00 | 0.00 | |
| Other Expenses | 44,977↑2616.0% | 1,656↓95.9% | 40,688↓12.6% | 46,548↑19.9% | 38,810 | |
| Operating Expenses | 44,977↑4.9% | 42,885↑5.4% | 40,688↓12.6% | 46,548↑19.9% | 38,810 | |
| Total Costs & Expenses | 391,682↑7.5% | 364,293↑5.9% | 344,033↑9.4% | 314,513↑12.8% | 278,801 | |
| Operating Results | ||||||
| Operating Income | 10,385↑21.9% | 8,516↓38.0% | 13,743↑72.8% | 7,954↓40.2% | 13,310 | |
| Depreciation & Amortization | 4,606↑0.2% | 4,597↑5.3% | 4,366↑3.4% | 4,224↓5.8% | 4,486 | |
| EBITDA | 9,861↓27.9% | 13,683↓24.8% | 18,197↑47.4% | 12,347↓29.6% | 17,526 | |
| EBIT | 5,255↓42.3% | 9,106↓34.2% | 13,831↑70.3% | 8,123↓37.7% | 13,040 | |
| Interest & Other Income | ||||||
| Net Interest Income | -3,119↓5.4% | -2,958↓11.3% | -2,658↓16.2% | -2,287↑8.6% | -2,503 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 3,119↑5.4% | 2,958↑11.3% | 2,658↑16.2% | 2,287↓8.6% | 2,503 | |
| Non-Operating Income | 5,130↑969.5% | -590↓570.5% | -88↑47.9% | -169↓162.6% | 270 | |
| Other Income / Expenses | -8,249↓248.4% | -2,368↑7.9% | -2,570↓21.3% | -2,118↑23.6% | -2,773 | |
| Income Before Tax | 2,136↓65.3% | 6,148↓45.0% | 11,173↑91.4% | 5,836↓44.6% | 10,537 | |
| Income Tax Expense | 408↓73.9% | 1,562↓44.3% | 2,805↑85.9% | 1,509↓40.8% | 2,548 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 1,728↓62.3% | 4,586↓45.2% | 8,368↑93.4% | 4,327↓45.8% | 7,989 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 1,768↓61.7% | 4,614↓44.7% | 8,344↑93.6% | 4,311↓46.1% | 8,001 | |
| Bottom-Line Net Income | 1,768↓61.7% | 4,614↓44.7% | 8,344↑93.6% | 4,311↓46.1% | 8,001 | |
| EPS (Basic) | 1.40↓61.7% | 3.66↓43.6% | 6.49↑97.3% | 3.29↓45.2% | 6.00 | |
| EPS (Diluted) | 1.39↓62.0% | 3.66↓43.4% | 6.47↑98.5% | 3.26↓45.2% | 5.95 | |
| Weighted Average Shares | 1,267↑0.6% | 1,259↓2.0% | 1,285↓2.1% | 1,312↓0.5% | 1,319 | |
| Weighted Average Diluted Shares | 1,271↑0.7% | 1,262↓2.2% | 1,290↓2.5% | 1,323↓0.5% | 1,329 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.